.png)
.webp)
.jpeg)
.webp)
.webp)
.jpeg)
Request a video call
Confirm Your Virtual Consultation
CellsTime Clinique - Regenerative Medicine Center Profile Overview
When Chronic Symptoms Lead You to Explore Regenerative Medicine
For many people living with a chronic, degenerative, autoimmune or musculoskeletal condition, searching for regenerative medicine is not the first step.
The search often begins after months or years of symptoms, specialist visits, medication, rehabilitation or concern about declining mobility and quality of life.
You may be searching because:
- Pain, stiffness, fatigue or condition-related symptoms continue despite earlier care
- Medication, rehabilitation, injections or other established treatments have not produced sufficient improvement
- You are comparing systemic infusion, localized injection or exosome-related options
- You want to know whether an advertised cell-based therapy is supported for your diagnosis
- You need a safe follow-up plan after returning home
Common searches include:
- “Mesenchymal stem cell therapy for knee pain in Tijuana”
- “Stem cell injections for shoulder pain in Mexico”
- “Regenerative medicine for hip pain and stiffness”
- “Systemic stem cell therapy for chronic inflammation symptoms”
- “Exosome therapy for joint pain in Tijuana”
- “Localized stem cell treatment for reduced mobility”
The official CellsTime website publicly lists mesenchymal stem cell applications and localized musculoskeletal injections. A separate PlacidWay provider profile also lists exosome-related services, IV wellness nutrition and aesthetic applications. These are descriptions of marketed services; they do not prove that a treatment is established, authorized for a particular condition or suitable for an individual patient.
Why People Research Regenerative Medicine?
People often begin researching regenerative treatments when symptoms continue, established options feel limited or they want another opinion. The decision may involve medical uncertainty, daily-life limitations, travel questions and concern about long-term safety.
What the Patient May Be Experiencing
- Persistent joint pain, stiffness or reduced range of motion
- A chronic autoimmune, metabolic or neurological diagnosis
- Fatigue, inflammation or reduced physical function
- Symptoms that continue despite treatment
- Concern that the condition may progress or limit independence
How Symptoms May Be Affecting Daily Life
- Difficulty walking, exercising, working or completing everyday tasks
- Reduced sleep quality, energy or concentration
- Dependence on pain medicine or frequent appointments
- Avoiding travel, family activities or social events
- Worry about future mobility, function or independence
Approaches the Patient May Have Tried
- Diagnosis-specific medication or specialist care
- Physical therapy, exercise or rehabilitation
- Pain-management procedures or standard injections
- Nutrition, sleep or lifestyle changes
- Surgery consultation or another medical opinion
- Research into legitimate clinical trials
What Often Triggers the Search Abroad
- A local clinician says available treatment is supportive rather than curative
- A clinic offers a cell-based protocol not routinely available at home
- Online testimonials or promotional claims describe improvement
- The patient is comparing price, dose, cell source or route
- A family member wants another option after standard care has not met expectations
Questions Behind the Search
- Is the proposed treatment established or experimental for my diagnosis?
- What type of cells or exosome product will be used, and where does it come from?
- Which doctor will evaluate and treat me?
- What Mexican authorization applies to the product, laboratory and Tijuana facility?
- What are the immediate and long-term risks?
- Who will manage complications and follow-up after I return home?
Am I a Candidate for Regenerative Medicine in Tijuana?
You may be considered for a regenerative medicine consultation when your diagnosis has been confirmed, relevant records are available and established treatment options have been reviewed. However, a diagnosis, a low quote, one test result or willingness to travel does not establish eligibility. A qualified clinician must evaluate the evidence for the exact product and condition, your medical risks and whether the possible benefits justify the uncertainty.
Treatment may be discussed when:
- The diagnosis is documented by an appropriate specialist
- Standard care, rehabilitation or other evidence-based options have been tried, are unsuitable or remain under informed discussion
- The cell source, processing method, dose, route, evidence and uncertainties can be explained in writing
- The patient understands that many regenerative uses remain experimental and results are not guaranteed
- Local follow-up and urgent-care access can be arranged before travel
The clinical team should assess:
- Diagnosis, severity, disease stability, specialist notes, imaging and laboratory results
- Infection, cancer, autoimmune, bleeding, pregnancy, allergy and immune-system history
- Heart, lung, liver and kidney function
- Prescription medicines, anticoagulants, immune-modifying drugs and supplements
- Previous procedures, current rehabilitation, functional goals and alternatives
- Product origin, donor screening, sterility, identity, dose and chain of custody
- Ability to remain for observation and continue long-term follow-up at home
Treatment may need to be postponed when:
- There is active infection, fever, uncontrolled illness or unstable symptoms
- The diagnosis or proposed treatment rationale is unclear
- Product identity, sterility, donor screening or regulatory documents are unavailable
- Medication, bleeding, allergy or immune risks have not been addressed
- There is no written emergency, monitoring or home follow-up plan
Important: A lower quote, convenient appointment, willingness to travel or provider marketing does not determine candidacy. A qualified clinician must make the decision after an appropriate assessment and a diagnosis-specific discussion of evidence, alternatives, risks and uncertainty.
Is CellsTime Clinique Right for Your Needs?
CellsTime Clinique may be relevant for adults comparing the publicly listed regenerative options. A safe decision requires diagnosis-specific evidence review, clinician credential checks, complete medical evaluation, product and laboratory documentation, complication planning and confirmed follow-up at home.
Quick Summary
- Location: Zona Urbana Río Tijuana, Baja California, Mexico
- Focus: Regenerative medicine and provider-described mesenchymal stem cell applications
- Options shown: Systemic applications, localized injections, exosome-related and IV wellness services
- Language support: English-language assistance is publicly described; confirm the language used for consultation and consent
- Key decision: What exact product, evidence, authorization and follow-up apply to your diagnosis?
About CellsTime Clinique in Tijuana
CellsTime Clinique provides regenerative medicine services through locations in Tijuana, Guadalajara and Cancún. Patients visiting the Tijuana clinic are directed to Fray Servando Teresa de Mier 1351, Zona Urbana Río Tijuana, C.P. 22010, Tijuana, Baja California, Mexico.
The cell-processing side of the program is connected with LCELLS, S.A. de C.V., which holds Mexican sanitary licence 12-TR-14-039-0001. Dated November 22, 2012, the licence covers a progenitor-cell bank and authorizes the handling of organs, tissues and cells for therapeutic purposes.
Material address discrepancy: the licence is tied to Longinos Cadena No. 1031, Guadalajara, Jalisco, while CellsTime currently gives Real de Acueducto 300 as its Guadalajara clinic address. It does not name the Tijuana location. Before treatment, ask where the cells are collected, processed, stored and released—and request documents showing how that licensed operation connects with the Tijuana clinic and your specific protocol.
A service list is not proof of clinical capability. What matters is whether the named licensed professionals, diagnosis-specific expertise, product controls, monitoring, emergency equipment and transfer pathway needed for the individual patient are available at the time of treatment.
| Provider fact | What the patient should verify |
|---|---|
| Accreditation or quality certification | Request the certificate number, legal holder, issuing certification body, accredited status of that body, scope, covered sites and current validity; verify it in the issuer’s directory. |
| Sanitary licence | Confirm current regulatory status, the different published Guadalajara address, the legal relationship to CellsTime Tijuana, facility-specific authorization and coverage of the exact product and clinical use. |
| International access | Confirm records transfer, consent language, transport, accessibility, payment terms and follow-up communication. |
| Emergency capability | Ask what emergency equipment and medicines are on site, who leads resuscitation, which hospital accepts transfers and who pays. |
Accreditation and licensing evaluate defined systems or permissions. They do not mean that every advertised treatment is established, that every patient is suitable or that an individual result is guaranteed.
Regenerative Treatment Options at CellsTime Clinique
The official provider website identifies systemic and localized mesenchymal stem cell services; the PlacidWay profile additionally lists exosome-related, IV wellness and aesthetic services. The appropriate intervention depends on the confirmed diagnosis, disease severity, anatomy, previous treatment, medicines, infection and immune risk, long-term goals and the evidence for the exact product. This table is a comparison aid, not a recommendation.
| Option | How it works |
|---|---|
| Systemic mesenchymal stem cell application Usually intravenous |
Provider materials describe cells administered systemically with the intention of influencing inflammatory or repair pathways. |
| Localized joint or musculoskeletal injection | A biological product is injected into or around a target such as a knee, shoulder or hip after clinical and imaging assessment. |
| Exosome-related therapy | Exosomes are extracellular vesicles involved in cell signalling. Provider materials associate them with regenerative and aesthetic applications. |
| IV wellness or aesthetic application | Provider materials describe intravenous nutrients and minimally invasive applications intended for wellness or skin-related goals. |
Medical Team and Clinician Verification
The central CellsTime website and PlacidWay materials identify the following clinicians in connection with the provider’s regenerative medicine services. This does not confirm which clinician will be assigned, which location each clinician attends or who will administer a particular product.
Verify the Assigned Clinical Team Before Paying
- Full name and current Mexican professional licence or cédula of the evaluating and treating clinician
- Relevant specialty certification and training for the diagnosis and proposed route
- Who selects, prepares, releases and administers the product
- Cell or exosome source, dose, batch number, sterility and viability documents
- Who provides after-hours and emergency coverage
- Facility privileges, professional liability arrangements and complaint pathway
The names, roles and licence numbers above are reproduced from provider-published materials; they were not independently matched to official Mexican professional-registry records during this review. The provider website also lists Dra. Edna Rosa Aguilar Rendón, Dra. María Guadalupe Navarro Barrientos and Dra. Ma. Yolanda Vargas Cabrera. Confirm current credentials, location and role directly in the official registry. Héctor Corona is identified by PlacidWay under clinical direction, but the reviewed sources do not establish a medical degree or professional licence; clarify whether this is an administrative or clinical role.
Risks, Evidence and Long-Term Responsibilities
A regenerative intervention may be intended to support symptoms, function or a biological pathway, but outcomes vary and are not guaranteed. For many advertised conditions, effectiveness and long-term safety remain uncertain. Diagnosis, baseline health, product source, processing, dose, route, technique, infection control, rehabilitation, follow-up and response to complications can all affect results.
| Time period | Potential concerns | Planning questions |
|---|---|---|
| Early | Pain, swelling, bruising, bleeding, fever, infection, allergic or infusion reaction, fainting, medication interaction or vascular/respiratory complication. | How long will I be observed? What monitoring and emergency medicines are available? Which symptoms trigger transfer? |
| Later | Persistent pain, injection-site or joint infection, immune effects, blood clot, delayed reaction, symptom worsening, no meaningful improvement or interruption of effective care. | Who reviews symptoms after discharge? What testing is planned? Who pays for reassessment or hospital care? |
| Long term | Durability may be unknown. Repeat-treatment pressure, financial burden, disease progression and delayed or unexpected adverse effects are possible. | Is there a monitoring or registry plan? How are adverse events reported? Will my home clinician receive product and batch records? |
Seek urgent medical care for trouble breathing, chest pain, fainting, new weakness or confusion, severe headache, high fever, rapidly worsening pain, spreading redness, drainage, marked limb swelling or any sudden or severe symptom. Do not wait for an overseas message reply if symptoms could represent a medical emergency.
International Regenerative Medicine Patient Journey: Complete Timeline
The timeline below shows how a responsible international treatment pathway may progress. Exact timing depends on the diagnosis, proposed product and route, medical risks, test results and recovery. A travel date should never be treated as final clinical clearance.
Starting Point
Define the Diagnosis and Treatment Goal
Document the confirmed diagnosis, symptoms, current care, functional limitations and what would count as meaningful improvement. Identify a home clinician willing to provide follow-up.
Initial Research
Compare Evidence, Alternatives and Providers
Compare the intervention with established treatment and legitimate clinical trials. Review independent guidance, not testimonials alone, and ask whether the exact use is experimental.
Before Travel
Submit Complete Medical Records
Provide specialist notes, medicines, allergies, imaging, laboratory results, previous procedures and infection history. Do not stop prescribed medicines without the prescribing clinician.
Clinical Review
Complete the Diagnosis-Specific Evaluation
An appropriate clinician should assess eligibility, alternatives, contraindications and the evidence for the exact product, dose, route and condition.
Decision Stage
Confirm the Team and Product
Obtain the clinician’s name and credentials plus product source, donor screening, sterility, characterization, batch-release, regulatory and informed-consent documents.
Planning Stage
Receive the Written Treatment and Cost Plan
Confirm product, dose, route, sessions, tests, observation, medicines, transport, lodging, exclusions, refunds, complication costs and follow-up.
Arrival in Tijuana
Complete In-Person Review and Final Clearance
Confirm identity, consent, product label and batch, treating team, emergency pathway, return-travel restrictions and who can accompany you.
Treatment
Undergo the Procedure and Monitoring
The team should complete final safety checks, document the product and procedure, monitor vital signs, maintain sterile technique and explain any change in plan.
Early Recovery
Meet Discharge and Travel Criteria
Leave only after documented discharge criteria are met and you have medicines, activity guidance, warning signs, contacts and a complete treatment record.
After Returning Home
Continue Diagnosis-Specific Follow-Up
Share product, batch, procedure and discharge documents with the home clinician. Continue appropriate standard care and use local urgent services for concerning symptoms.
Travel-safety reminder: Recent treatment, sedation, pain, dehydration, reduced mobility and prolonged sitting may increase travel-related risk. The treating team should determine when flying, driving long distances or crossing the border is appropriate.
Frequently Asked Questions
What treatments does CellsTime Clinique offer?
Public provider materials list systemic mesenchymal stem cell applications, localized musculoskeletal injections, exosome-related services, IV wellness nutrition and aesthetic applications. Availability, evidence and suitability must be confirmed individually.
Which regenerative treatment option may be right for me?
Only a qualified clinician who has reviewed your diagnosis, records, established alternatives, risks and the evidence for the exact product can advise you. A quote or general diagnosis cannot determine candidacy.
Which doctors are associated with CellsTime Clinique?
The provider website lists several clinicians, including Dra. Irydia Guadalupe Pellegrini Verduzco and Dr. Hiram Fernández Santana. Confirm the assigned clinician, current credentials, Tijuana location and exact role before payment.
How long should I stay in Tijuana after treatment?
There is no universal safe stay. Timing depends on the route, health risks, reaction, observation needs and access to urgent care. Ask for written discharge and travel-clearance criteria.
What follow-up will I need after returning home?
Arrange diagnosis-specific review with a home clinician, share the product and batch information and procedure record, continue appropriate care and agree on symptom, laboratory, imaging, rehabilitation and adverse-event monitoring.
What should I ask about emergency care and complications?
Ask what emergency equipment and trained staff are on site, which hospital accepts transfers, who remains responsible after discharge, what symptoms need immediate local care and who pays for transfer or extended treatment.
Request More Information About Your Regenerative Medicine Options
Share your medical history for a preliminary review and request a written explanation of candidacy, treatment evidence, product details, clinician credentials, estimated costs and follow-up arrangements.
Request a Free, No-Obligation QuoteMedical Disclaimer
This information is educational and does not replace evaluation, diagnosis or advice from a licensed clinician who knows your medical history. Cell-based, exosome-related, injection and IV procedures can have immediate and long-term risks; many uses remain experimental, evidence varies by condition and product, and individual results vary. Provider affiliations, doctors, licences, accreditations, products, procedures, prices and travel arrangements can change; verify them directly and independently before making a medical or financial commitment. U.S. FDA status and Mexican regulatory status are different questions. Seek urgent local medical care for severe or rapidly worsening symptoms.
References and Verification Sources
- PlacidWay — CellsTime Clinique Tijuana
- CellsTime Clinique — Provider website, locations, treatments and medical team
- Provider-linked sanitary licence PDF — LCELLS, S.A. de C.V.
- Mexico Secretariat of Public Education — official professional-licence registry
- U.S. FDA — Patient information about regenerative medicine therapies
- International Society for Stem Cell Research — Guide to Stem Cell Treatments
CellsTime Clinique - Regenerative Medicine Center Certificates
Location
About Medical Center
- Speciality: Anti Aging, Stem Cell Therapy for Longevity
- Location: Fray Servando Teresa de Mier 1351, Zona Urbana Rio Tijuana, B.C. , Tijuana 22010 , Mexico
- Overview: Begin your wellness journey at CellsTime Clinique in Tijuana, Mexico, offering advanced stem cell therapy in a convenient location with support for various health concerns and transportation available
Share this listing